Mobile

An exploratory pharmacogenomic study of cetuximab monotherapy in patients with metastatic EGFR-Positive colorectal carcinoma

Update Il y a 4 ans
Reference: EUCTR2004-002837-37

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To explore whether Muc 2, Muc 3, CFTR, SERPINB-5, BMP-2, BTC, TLN2, EPHA1, HMGCoA or Spondin expression can predict response to CETUXIMAB treatment.

Inclusion criteria

  • Metastatic Colorectal Carcinoma

Links